A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Litwin Zucker Research Ctr.; Feinstein Inst. Med. Rsch., Manhasset

The Clinical Trial Center, LLC, Jenkintown

Dekalb Neurology Associates, Decatur

Hôpital Casselardit; Cons memoire, Toulouse

Compass Research, Orlando

MD Clinical, Hallandale

Internal Med Assoc of Lee Cty, Fort Myers

Neuropsychiatric Research; Center of Southwest Florida, Fort Myers

Clinique Psychiatrique Univ, Tours

Hattiesburg Clinic, Hattiesburg

Neurology & Neuroscience Ctr of Ohio, Toledo

Hopital Central-CHU de Nancy; Pharmacie, Nancy

Alexian Brothers Neurosci Inst, Elk Grove Village

Banner Alzheimer's Institute, Phoenix

Banner Sun Health Research Insitute, Sun City

NNS Clinical Research LLC, Tucson

Cleveland Clinic Lou Ruvo; Center for Brain Research, Las Vegas

University of California Los Angeles (UCLA), Los Angeles

Pacific Neuroscience Med Grp, Oxnard

Margolin Brain Institute, Fresno

Stanford Univ Medical Center, Palo Alto

Redwood Regional Medical Group, Santa Rosa

Memory Enhancement Center of America, Inc., Eatontown

Rhode Island Mood & Memory Research Institute, East Providence

Butler Hospital, Providence

Fundació ACE, BArcelon

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

Hospital del Mar, Barcelona

Hospital Mutua De Terrasa, Barcelona